Neuroscience
Multiple Sclerosis
100%
Peroxisome Proliferator-Activated Receptor
27%
Metabolic Pathway
26%
Interferon
21%
Apolipoprotein E
20%
Relapsing Remitting Multiple Sclerosis
17%
Glutamate Ammonia Ligase
16%
Myelin
16%
Cerebroside
12%
Blood Plasma
12%
Neurodegenerative Disorder
10%
Sulfatide
10%
Sulfotransferase
10%
CD36
10%
Diagnosis of Multiple Sclerosis
10%
Gene Expression
9%
Expanded Disability Status Scale
9%
Nervous System
9%
Neutralizing Antibody
9%
Beta Interferon
9%
Natalizumab
9%
Ferritin
9%
Glutamic Acid
9%
Apolipoprotein
9%
Receptor Expression
9%
Fingolimod
9%
Microglia
9%
Adiponectin
9%
Differential Diagnosis
9%
Intrathecal
9%
Immunoglobulin A
9%
Triiodothyronine
9%
In Vitro
9%
Amino Acid Neurotransmitter
6%
Glutamate Dehydrogenase
6%
Oligodendrocyte
6%
Phosphatase
6%
Cyclic Nucleotide
6%
Magnetic Resonance Imaging
6%
Central Nervous System
5%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Sclerosis
51%
Peroxisome Proliferator Activated Receptor
27%
Lipoprotein
16%
Apolipoprotein E
13%
Diseases
11%
Chick
9%
Glutamate Ammonia Ligase
9%
Obesity
9%
Beta Interferon
9%
Fingolimod
9%
Neutralizing Antibody
9%
Natalizumab
9%
Oral Contraceptive
9%
Oral Contraceptive Agent
9%
Interferon
9%
Liothyronine
9%
Cerebroside
9%
Sulfatide
9%
Sulfotransferase
9%
Myelin
6%
High Density Lipoprotein 2
6%
Medicine and Dentistry
Cardiometabolic Risk
18%
Biological Marker
18%
Diseases
13%
Diagnosis of Multiple Sclerosis
9%
Multiple Sclerosis
9%
Moyamoya Disease
9%
Mitochondrial Encephalomyopathy
9%
Differential Diagnosis
9%
Cardiovascular Disease
8%
Physician
8%
Magnetic Resonance Imaging
6%
